CoChat

CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication

Open access

The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index; 30 of the 114 sources its claims cite were checked for support.

Abstract

p21Waf/CIP1 is a small unstructured protein that binds and inactivates cyclin-dependent kinases (CDKs). To this end, p21 levels increase following the activation of the p53 tumor suppressor. CDK inhibition by p21 triggers cell-cycle arrest in the G1 and G2 phases of the cell cycle. In the absence of exogenous insults causing replication stress, only residual p21 levels are prevalent that are insufficient to inhibit CDKs. However, research from different laboratories has demonstrated that these residual p21 levels in the S phase control DNA replication speed and origin firing to preserve genomic stability. Such an S-phase function of p21 depends fully on its ability to displace partners from chromatin-bound proliferating cell nuclear antigen (PCNA). Vice versa, PCNA also regulates p21 by preventing its upregulation in the S phase, even in the context of robust p21 induction by γ irradiation. Such a tight regulation of p21 in the S phase unveils the potential that CDK-independent functions of p21 may have for the improvement of cancer treatments.

Overview

CoChat Summary

TL;DR

This review argues that p21 has CDK-independent, PCNA-dependent functions in S phase: residual p21 modulates DNA replication speed and origin firing, while p21 is actively degraded in S phase even after DNA damage. These S-phase functions may be relevant to cancer therapy, particularly through effects on translesion synthesis.

Key findings

  • p21 is a 165-amino-acid protein; its C-terminal PCNA-binding region (aa139–164) contains a PIP degron with core QTSMTDFY (aa144–151). Flanking sequences contribute strongly: removing them drops PCNA affinity 10-fold, and replacing them with hydrophilic or negatively charged sequences reduces affinity by four orders of magnitude.
  • In S phase, p21 remains at its lowest or undetectable levels and is not upregulated by γ irradiation, NCS, or nutlin-3; CRL4Cdt2 degrades PCNA-bound p21. Cellular p21/PCNA ratios reportedly never exceed 1:1, whereas blocking NER in vitro requires ≥10:1 and blocking replicative DNA synthesis in vitro requires 100:1, making direct inhibition of replicative polymerases by endogenous S-phase p21 unlikely.
  • Residual S-phase p21 is a positive regulator of nascent DNA elongation: p21 downregulation impairs elongation and increases common fragile-site instability and micronuclei, via dysregulated pol κ loading onto PCNA. A separate report found p21 downregulation increased fork elongation, but both support that residual p21 controls replication speed.
  • In p53-deficient models, p21 overexpression caused CDT1/CDC6/ORC upregulation, rereplication, asymmetric slow forks, and DSBs; p21–PCNA interaction prevented chromosome fusions and micronuclei. After UV, p21 downregulation permits TLS, whereas stable p21 blocks recruitment of pol η, κ, ι, and Rev1 and increases cell death and genomic instability.

Methods

  • Narrative review; no primary experimental data. It synthesizes published literature on p21, PCNA, CDKs, DNA replication, DDR, TLS, and cancer therapy.
  • Evidence discussed includes cell lines (e.g., MCF-7, SAOS-2, HCT116, Li-Fraumeni fibroblasts), C. elegans, live-cell imaging, single-cell analysis, in vitro binding/replication assays, and tumor marker colocalization; no systematic search or meta-analysis is described.

Limitations

  • Stated: The review notes unresolved issues: whether cellular p21 levels suffice to displace replicative DNA polymerases from active replisomes; the mechanism by which S-phase p21–PCNA interaction triggers arrest outside S phase; inconclusive in vivo NER effects; and conflicting reports on whether p21 downregulation reduces or increases fork elongation, with different siRNAs and no p21-null models in one study.
  • Evident: As a narrative review, it lacks a systematic search strategy, formal quality assessment, or quantitative synthesis; conclusions rely on selected literature and author interpretation.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/genes11060593

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 p21 binds cyclin/CDKs and PCNA. Scheme depicting sites of p21 binding partners and detailed regions within PCNA binding region. Threonine (Aspartic acid (TD) at position 148–149 and basic residue (R) in position 155 constitute the degron that is underlined in the model and detailed below. NLS, nuclear localization signal.
Figure 1 p21 binds cyclin/CDKs and PCNA. Scheme depicting sites of p21 binding partners and detailed regions within PCNA binding region. Threonine (Aspartic acid (TD) at position 148–149 and basic residue (R) in position 155 constitute the degron that is underlined in the model and detailed below. NLS, nuclear localization signal.CC BY · PubMed Central
Figure 2 Cell cycle imposes strong regulation on p21 levels in S phase. Levels of fluorescence-tagged p21, PCNA, and CDK activities presented by black, purple, and orange lines, respectively. Endogenous p21 levels not shown, as live image experiments focused on fluorescence-tagged p21. Only in G1 and G2 did p21 levels rise to an extent that could inhibit cyclin–kinase complexes such as CycE/CDK2. Since p21 levels in G1 are very heterogeneous, multiple black lines represent such dispersion in p21 expression. Length of the G1 phase correlates with p21 levels, which were higher than p21 levels in Phase G2 [16]. Whether p21 controls PCNA functions in G1 is still debated, but p21 overexpression levels, which are similar to highest levels reached by endogenous p21 after DNA damage, are not sufficient to modulate replicative DNA synthesis or nucleotide excision repair in G1 [51]. In S phase, levels of fluorescence-tagged p21 were undetectable both in unperturbed conditions and after γ-irradiation, nutlin-3, or neocarzinostatin (NCS) treatment, which are all well-characterized inducers of p21 [16,67,68]. These results indicate that excess of exogenous p21 is strongly prevented in the S phase. Either Cdt2 downregulation or the disruption of the PIP box of p21 allowed p21 upregulation in the S phase, indicating CRL4Cdt2 that degrades PCNA-bound p21, tightly controlling p21 levels in the S phase [16,67]. p21 represented as black linear and unstructured peptide; dotted p21 represent p21 degradation.
Figure 2 Cell cycle imposes strong regulation on p21 levels in S phase. Levels of fluorescence-tagged p21, PCNA, and CDK activities presented by black, purple, and orange lines, respectively. Endogenous p21 levels not shown, as live image experiments focused on fluorescence-tagged p21. Only in G1 and G2 did p21 levels rise to an extent that could inhibit cyclin–kinase complexes such as CycE/CDK2. Since p21 levels in G1 are very heterogeneous, multiple black lines represent such dispersion in p21 expression. Length of the G1 phase correlates with p21 levels, which were higher than p21 levels in Phase G2 [16]. Whether p21 controls PCNA functions in G1 is still debated, but p21 overexpression levels, which are similar to highest levels reached by endogenous p21 after DNA damage, are not sufficient to modulate replicative DNA synthesis or nucleotide excision repair in G1 [51]. In S phase, levels of fluorescence-tagged p21 were undetectable both in unperturbed conditions and after γ-irradiation, nutlin-3, or neocarzinostatin (NCS) treatment, which are all well-characterized inducers of p21 [16,67,68]. These results indicate that excess of exogenous p21 is strongly prevented in the S phase. Either Cdt2 downregulation or the disruption of the PIP box of p21 allowed p21 upregulation in the S phase, indicating CRL4Cdt2 that degrades PCNA-bound p21, tightly controlling p21 levels in the S phase [16,67]. p21 represented as black linear and unstructured peptide; dotted p21 represent p21 degradation.CC BY · PubMed Central
Figure 3 Alterations of endogenous p21 levels in S phase cause genomic instability. Endogenous p21 S normal levels are within the segmented gray box, interacting with PCNA in replication factories [79]. Such p21 levels are required to maintain genomic stability. Both positive and negative changes in p2l levels are detrimental to cell genomic stability. (bottom) Downregulation of p21 levels in S causes alterations in nascent DNA elongation speed in a manner that depends on p21–PCNA interaction [79,82]. Mechanism underlying the promotion of nascent DNA elongation by p21 involves the prevention of dysregulated loading of specialized polymerases to sites of DNA synthesis, favoring the utilization of processive polymerases on undamaged templates. Under such experiment settings, p21 downregulation causes genomic instability in a manner that depends on loss of p21–PCNA interaction [79]. The deaccelerating role of p21, oppositely, also depends on p21–PCNA interaction [82]. (top) While p53-proficient cells do not allow p21 upregulation in the S phase, p53-deficient cells escaping from a senescent-like phenotype allow DNA replication in the context of p21 overexpression. Increased p21 levels in the S phase saturate the CRL4Cdt2 E3 ligase, causing an upregulation of other CRL4Cdt2 targets involved in origin firing [71]. Alterations in replication choreography are followed by rereplication events and double-strand-break (DSB) accumulation that are channeled into error-prone repair, further fueling cell genomic instability [71,75].
Figure 3 Alterations of endogenous p21 levels in S phase cause genomic instability. Endogenous p21 S normal levels are within the segmented gray box, interacting with PCNA in replication factories [79]. Such p21 levels are required to maintain genomic stability. Both positive and negative changes in p2l levels are detrimental to cell genomic stability. (bottom) Downregulation of p21 levels in S causes alterations in nascent DNA elongation speed in a manner that depends on p21–PCNA interaction [79,82]. Mechanism underlying the promotion of nascent DNA elongation by p21 involves the prevention of dysregulated loading of specialized polymerases to sites of DNA synthesis, favoring the utilization of processive polymerases on undamaged templates. Under such experiment settings, p21 downregulation causes genomic instability in a manner that depends on loss of p21–PCNA interaction [79]. The deaccelerating role of p21, oppositely, also depends on p21–PCNA interaction [82]. (top) While p53-proficient cells do not allow p21 upregulation in the S phase, p53-deficient cells escaping from a senescent-like phenotype allow DNA replication in the context of p21 overexpression. Increased p21 levels in the S phase saturate the CRL4Cdt2 E3 ligase, causing an upregulation of other CRL4Cdt2 targets involved in origin firing [71]. Alterations in replication choreography are followed by rereplication events and double-strand-break (DSB) accumulation that are channeled into error-prone repair, further fueling cell genomic instability [71,75].CC BY · PubMed Central
Figure 4 p21 overexpression in S phase triggers cell death by preventing DNA replication across DNA lesions. A) Endogenous p21 is degraded at sites of DNA lesions. Elimination of p21 [50] and concomitant ubiquitination of PCNA [24,98] promote loading of specialized DNA polymerases at forks stalled at DNA lesions [50]. In this way, p21 prevents loading such polymerases in undamaged templates [79], but when DNA lesions are encountered by replication forks, rapid CRLCdt2-mediated removal of p21 facilitates replication across DNA lesions (dotted p21 represents p21 degradation) [50]. B) When p21 degradation is prevented in the context of high PCNA ubiquitination, the recruitment of specialized polymerases to replication factories is impaired. Replicative polymerases stall persistently at DNA lesions, and forks collapse, triggering cell death and genomic instability [50]. Stable p21–PCNA interaction is essential for such a role of p21 in TLS inhibition.
Figure 4 p21 overexpression in S phase triggers cell death by preventing DNA replication across DNA lesions. A) Endogenous p21 is degraded at sites of DNA lesions. Elimination of p21 [50] and concomitant ubiquitination of PCNA [24,98] promote loading of specialized DNA polymerases at forks stalled at DNA lesions [50]. In this way, p21 prevents loading such polymerases in undamaged templates [79], but when DNA lesions are encountered by replication forks, rapid CRLCdt2-mediated removal of p21 facilitates replication across DNA lesions (dotted p21 represents p21 degradation) [50]. B) When p21 degradation is prevented in the context of high PCNA ubiquitination, the recruitment of specialized polymerases to replication factories is impaired. Replicative polymerases stall persistently at DNA lesions, and forks collapse, triggering cell death and genomic instability [50]. Stable p21–PCNA interaction is essential for such a role of p21 in TLS inhibition.CC BY · PubMed Central

Verification

Claims the paper makes

22 Valid · 1 Not valid · 51 Not checked · 24 Own results and interpretations

69 more claims · 15 with their cited sources checked

Create a free account to see all 98 claims and to verify the 84 references still open.

See all claims — free account
  • It may state two separate claims as one. 17
  • Probably not a substantial claim. 9

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Cited by

See all 114

Metadata

Authors
Mansilla, S. F., De La Vega, M. B., Calzetta, N. L., Siri, S. O., & Gottifredi, V.
Affiliations
  • Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
  • Cell Cycle and Genomic Stability Laboratory, Fundación Instituto Leloir, IIBBA-CONICET, Av. Patricias Argentinas 435, Buenos Aires 1405, Argentina
Corresponding author
Gottifredi, Vanesa
Venue
Genes
Publisher
MDPI AG
Published
2020-05-28
Volume
11
Issue
6
Pages
593
ISSN
2073-4425 (ISSN-L)
OpenAlex
W3030260166
Cited by
114
References
125
Citations by year
2026: 10 · 2025: 18 · 2024: 22 · 2023: 22 · 2022: 20 · 2021: 16 · 2020: 5
FWCI
1.69
Type
journal article
Language
en
Open access
Locations
  • Genes (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • CONICET Digital (CONICET) (submittedVersion, cc-by-nc-sa)
Funders
  • Agencia Nacional de Promoción Científica y Tecnológica (PICT 2016- 1239, PICT 2017-0612)
  • Instituto Nacional del Cáncer (No grant number)
  • Ben Barres spotlight award from eLIFE (No grant number)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
Keywords
p21, DNA replication, cyclin-dependent kinases, PCNA, S phase, origin firing, genome stability, p53, cell cycle arrest, chromatin binding, cancer therapy
MeSH terms
DNA Replication, Humans, S Phase, Proliferating Cell Nuclear Antigen, Cyclin-Dependent Kinases, Protein Kinase Inhibitors, Cyclin-Dependent Kinase Inhibitor p21

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.